GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA-regulated for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition. Las Vegas runs around the clock, and dealers, servers, performers and resort staff working overnight and rotating shifts rarely fit a daytime clinic into their week - even as the job keeps appearance and stamina front of mind. Telehealth works on their clock: a licensed Nevada physician reviews your online assessment under Nevada Revised Statutes §629.515, and compounded medication from an FDA-registered 503B pharmacy ships to your Las Vegas address. Monthly cost runs $199–$379 versus about $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Serving Las Vegas ZIP codes: 89101, 89102, 89104, 89109, 89119.
Local clinics serving Downtown: Genesis Lifestyle Medicine, Medi-Slim Weight Loss & Spa and Medical Reducing Inc. Many patients compare these in-person options against licensed GLP-1 telehealth — prescribed online, shipped to the door.
Ozempic seen from Downtown, without the jargon. Many patients who ask for 'Ozempic for weight loss' are actually steered toward compounded semaglutide or Wegovy, depending on the medical evaluation and cost.
Beyond the sticker price, look at what is included: consultation, titration, refills, and shipping are sometimes bundled into a single monthly fee. Without insurance coverage, the brand-name price climbs fast; that is what pushes most patients to compare subscription programs that bundle the medication, monitoring, and delivery.
Around Downtown in Clark County, 3 weight-management practice(s) are listed locally. In this state, Nevada Revised Statutes §629.515; the reference body is Nevada State Board of Medical Examiners. Ozempic belongs to the 'GLP-1 agonist (brand of semaglutide, diabetes indication)' class and is given as a weekly subcutaneous injection. Typical dosing: 0.25 mg to start, then 0.5 / 1.0 / 2.0 mg by glycemic response and tolerance.
That is an off-label use. Many physicians prescribe it, but the FDA indication for weight loss is Wegovy (same active ingredient, semaglutide, at a higher dose).
Coverage varies by plan and indication; many patients without coverage opt for a compounded formula at a fixed monthly cost.
Same molecule (semaglutide). Ozempic is dosed/approved for diabetes, Wegovy for chronic weight loss.
Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Licensed in Nevada. All prescriptions issued under Nevada Revised Statutes §629.515 and supervised by Nevada State Board of Medical Examiners.